Member Info for Kjn2

I meant to say “doesn’t” of course.

In practice it does work that way. The board and company need to prove to the panel that an active offer period is required. Fiduciary duty exists.

Ukstock Kendall tends to be outright rude, no point having a proper discussion with that user. He should have been removed here and other forums long time ago. Spamming the forum with made up stuff. I just checked, cannot find £3.40 offer anywhere.

Some corrections:

- what is the source for Toscafund and Mediclinic demanding £3 per share? Is this new? Google / Gemini isn’t finding any evidence. Maybe that’s the “ask” and they would settle at 260-270. There is no way in my view another sale process can be launched within the next 24-36 months, the Board and owners would be considered (fill the gap).

- there have been hospitals deals in the UK, the government has never and in my view will never intervene. They aren’t the owners and have bigger fish to fry with the NHS. Only the CMA could commence a process.

- the share price hasn’t hit brokers forecasts in years, sell wide is always more bullish, that’s their business model. I can imagine some have a takeover premium implemented in their targets.

I am surprised that the stock isn’t at 180 levels. That’s the level before the Pusu was announced.

Curious to see what the main holders and all shareholders are going to do with the Board at the AGM. Awarding ltip while the deal fell apart is obviously a terrible look and 6 months ago the stock was at 240 vs 160 today.

At some point their stakes become too big on a relative basis and absolute basis internally imo.

More importantly, maybe they don’t want to restrict themselves? Valid point though, if they really thought this can sell for 50-70% higher why wouldn’t they buy more.

I think it was a press release only.

“ If you’re evaluating Mr Griffiths specifically in UK takeover situations:

✅ Consistent participant in companies that end up in takeover or restructuring scenarios

✅ Often a meaningful minority shareholder who can influence outcomes”

Kendall, the clown show is back. No one missing your posts.

Decent volume today vs market. After 7 months of offer period time for a value creating outcome. Even Morrisons didn’t take that long.

Your post makes zero sense. Hedged or not, the setup as I outline could result in a squeeze. Completely irrelevant if hedged or not. Why don’t you post something that is of value add to all of us? Just once.

I’m surprised to see disclosed shorts here. Altogether at least 2.5% or around 10 million shares. Some days the stock trades 600-700k shares only which means it would take more than 20 days or so to cover. Risky short in my view.

And yet another false/trash post of yours. 10 years ago they had a 314p bid, not 350p. Completely irrelevant.

What’s your problem with Chris Harwood? Jealous of him?

That’s not right, Mediclinic bought their stake for 360p, there wasn’t an offer for the entire company.

Shareholders are right to point out the poor long term share performance I think. And it’s also ok to criticize how long the review has taken. More than half a year is a joke. Let’s not forget Board members get paid very well. And if main owners want to sell it’s in their right.

Once you know how to spell we can actually comprehend your posts.

Just looking at the numbers, either Sky was way off or the reporter mixed up equity and EV. 1500 is 372p and 1000 is 248p, all over the place.

UK: I wouldn’t take the Sky reports for granted, decent chance the reporter got mixed up?

No one cares about your 2 cents Kendall, literally.

The market pays attention to him, no one to you.

Yet another 8.3 today

Shareholders can vote for the AGM, good luck to the board / management to get re-elected and get their compensation approved.

Gresham 8.3 today shows 1.17% stake left and that they sold shares.

Mr Richard Griffith has increased its stake, so has BlackRock. Gresham keep selling.

Kendall your posts are as useless as they get. You probably believe posters like Jack judging your misinformed posts.